FdaApplication
NDA 214783
Identifiers
- fda_app_no: NDA214783
Properties
| Property | Value |
|---|---|
| applicant_name | KADMON PHARMACEUTICALS LLC |
| application_type | NDA |
| approval_date | 2021-07-16 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| REZUROCK | BELUMOSUDIL MESYLATE | EQ 200MG BASE | TABLET;ORAL |
1 product